BioWorld MedTech

Nov. 17, 2011

AHA notebook: Berlin Heart unveils favorable data from Excor clinical trial

The Berlin Heart Group (Woodlands, Texas/Berlin) unveiled clinical trial data presented yesterday at the "Scientific Sessions 2011" annual meeting of the American Heart Association (AHA; Washington). Read More

CooperVision recall expanded, management credibility hit

International report: Boston Sci's Watchman implanted in first Latin American patients

Washington roundup: FDA spells out new staged IDE approval in new draft guidance

Financings roundup: Unilife prices offering, expects to raise $34M

Deals roundup: AptarGroup acquires minority interest in OVal for $3.2M

Agreements/contracts: Genisphere to supply RNA technology to Affymetrix

New ventures: Optum launches institute for sustainable health

Med-Tech Notes: Digital Assent opens more offices

HIT roundup: Methodist Hospital to deploy SciQuest's eMarketplace

Product Briefs

People in the News

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...